Loxo Oncology Inc (LOXO.OQ) Key Developments | Reuters.com
United States

Analyst Research

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : ValuEngine, Inc.
Provider : Reuters Investment Profile
Provider : Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Loxo Oncology Inc announces pricing of IPO

Friday, 1 Aug 2014 06:00am EDT 

Loxo Oncology Inc:Pricing of its initial public offering of 5,261,538 shares of its common stock at price to public of $13.00 per share.Shares are expected to begin trading on NASDAQ Global Market on Aug. 1 under symbol LOXO.Granted underwriters 30-day option to purchase up to 789,230 additional shares of common stock from Loxo Oncology at same price to cover over-allotments.Selling through private placement 230,769 shares of its common stock to New Enterprise Associates 14, L.P., an existing stockholder, at initial public offering price.Cowen and Company, LLC and Stifel are acting as joint book-running managers for the offering.JMP Securities LLC and Oppenheimer & Co. Inc. are acting as co-managers.Registration statement relating to securities to be sold in offering has been filed with U.S. Securities and Exchange Commission and was declared effective on July 31. 

Company Quote

0.73 +3.19%
4:00pm EDT